181 related articles for article (PubMed ID: 32376340)
1. Roles for lysophosphatidic acid signaling in vascular development and disease.
Smyth SS; Kraemer M; Yang L; Van Hoose P; Morris AJ
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158734. PubMed ID: 32376340
[TBL] [Abstract][Full Text] [Related]
2. Coronary Artery Disease Risk-Associated
Mueller PA; Yang L; Ubele M; Mao G; Brandon J; Vandra J; Nichols TC; Escalante-Alcalde D; Morris AJ; Smyth SS
Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2261-2272. PubMed ID: 31533471
[TBL] [Abstract][Full Text] [Related]
3. Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease.
Jose A; Kienesberger PC
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502491
[TBL] [Abstract][Full Text] [Related]
4. Lipid phosphate phosphatase 3 negatively regulates smooth muscle cell phenotypic modulation to limit intimal hyperplasia.
Panchatcharam M; Miriyala S; Salous A; Wheeler J; Dong A; Mueller P; Sunkara M; Escalante-Alcalde D; Morris AJ; Smyth SS
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):52-9. PubMed ID: 23104851
[TBL] [Abstract][Full Text] [Related]
5. Mice with targeted inactivation of ppap2b in endothelial and hematopoietic cells display enhanced vascular inflammation and permeability.
Panchatcharam M; Salous AK; Brandon J; Miriyala S; Wheeler J; Patil P; Sunkara M; Morris AJ; Escalante-Alcalde D; Smyth SS
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):837-45. PubMed ID: 24504738
[TBL] [Abstract][Full Text] [Related]
6. Regulation of PLPP3 gene expression by NF-κB family transcription factors.
Mao G; Smyth SS; Morris AJ
J Biol Chem; 2019 Sep; 294(38):14009-14019. PubMed ID: 31362988
[TBL] [Abstract][Full Text] [Related]
7. Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction.
Tripathi H; Al-Darraji A; Abo-Aly M; Peng H; Shokri E; Chelvarajan L; R Donahue R; Levitan BM; Gao E; Hernandez G; Morris AJ; Smyth SS; Abdel-Latif A
J Mol Cell Cardiol; 2020 Dec; 149():95-114. PubMed ID: 33017574
[TBL] [Abstract][Full Text] [Related]
8. Signalling by lysophosphatidate and its health implications.
Hemmings DG; Brindley DN
Essays Biochem; 2020 Sep; 64(3):547-563. PubMed ID: 32451553
[TBL] [Abstract][Full Text] [Related]
9. Targeting the autotaxin - Lysophosphatidic acid receptor axis in cardiovascular diseases.
Zhao Y; Hasse S; Zhao C; Bourgoin SG
Biochem Pharmacol; 2019 Jun; 164():74-81. PubMed ID: 30928673
[TBL] [Abstract][Full Text] [Related]
10. Lipid phosphate phosphatase 3 in smooth muscle cells regulates angiotensin II-induced abdominal aortic aneurysm formation.
Van Hoose PM; Yang L; Kraemer M; Ubele M; Morris AJ; Smyth SS
Sci Rep; 2022 Apr; 12(1):5664. PubMed ID: 35383201
[TBL] [Abstract][Full Text] [Related]
11. Cardiac-specific inactivation of LPP3 in mice leads to myocardial dysfunction and heart failure.
Chandra M; Escalante-Alcalde D; Bhuiyan MS; Orr AW; Kevil C; Morris AJ; Nam H; Dominic P; McCarthy KJ; Miriyala S; Panchatcharam M
Redox Biol; 2018 Apr; 14():261-271. PubMed ID: 28982073
[TBL] [Abstract][Full Text] [Related]
12. Role of lipid phosphate phosphatase 3 in human aortic endothelial cell function.
Touat-Hamici Z; Weidmann H; Blum Y; Proust C; Durand H; Iannacci F; Codoni V; Gaignard P; Thérond P; Civelek M; Karabina SA; Lusis AJ; Cambien F; Ninio E
Cardiovasc Res; 2016 Dec; 112(3):702-713. PubMed ID: 27694435
[TBL] [Abstract][Full Text] [Related]
13. LPP3 localizes LPA6 signalling to non-contact sites in endothelial cells.
Yukiura H; Kano K; Kise R; Inoue A; Aoki J
J Cell Sci; 2015 Nov; 128(21):3871-7. PubMed ID: 26345369
[TBL] [Abstract][Full Text] [Related]
14. Lipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activity.
Smyth SS; Sciorra VA; Sigal YJ; Pamuklar Z; Wang Z; Xu Y; Prestwich GD; Morris AJ
J Biol Chem; 2003 Oct; 278(44):43214-23. PubMed ID: 12909631
[TBL] [Abstract][Full Text] [Related]
15. Lipid phosphate phosphatase (LPP3) and vascular development.
Ren H; Panchatcharam M; Mueller P; Escalante-Alcalde D; Morris AJ; Smyth SS
Biochim Biophys Acta; 2013 Jan; 1831(1):126-32. PubMed ID: 22835522
[TBL] [Abstract][Full Text] [Related]
16. The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
Magkrioti C; Oikonomou N; Kaffe E; Mouratis MA; Xylourgidis N; Barbayianni I; Megadoukas P; Harokopos V; Valavanis C; Chun J; Kosma A; Stathopoulos GT; Bouros E; Bouros D; Syrigos K; Aidinis V
Cancer Res; 2018 Jul; 78(13):3634-3644. PubMed ID: 29724718
[TBL] [Abstract][Full Text] [Related]
17. Structure-function relationships of autotaxin, a secreted lysophospholipase D.
Hausmann J; Perrakis A; Moolenaar WH
Adv Biol Regul; 2013 Jan; 53(1):112-7. PubMed ID: 23069371
[TBL] [Abstract][Full Text] [Related]
18. Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.
Smyth SS; Mueller P; Yang F; Brandon JA; Morris AJ
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):479-86. PubMed ID: 24482375
[TBL] [Abstract][Full Text] [Related]
19. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.
Samadi N; Bekele R; Capatos D; Venkatraman G; Sariahmetoglu M; Brindley DN
Biochimie; 2011 Jan; 93(1):61-70. PubMed ID: 20709140
[TBL] [Abstract][Full Text] [Related]
20. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
